Catalyst Wire Dossier Catalyst Wire Dossier

St. John's Wort Extract LI 160

Hypericum perforatum extract LI 160 · Cassella-med GmbH & Co. KG
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for St. John's Wort Extract LI 160, covering 2009-03-16 to 2009-03-16. Get the full timeline:

Most recent: Clinical Trial Update: St. John's Wort Extract LI 160 for the Treatment of Atypical Depression [Phase 3]

See pricing